Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
收藏DataCite Commons2025-12-05 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012068/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This trial is conducted globally. The aim of this trial is to investigate dose-finding of semaglutide administered subcutaneously once daily versus placebo and liraglutide in subjects with type 2 diabetes
提供机构：
Vivli
创建时间：
2025-12-05
